No Stimulus Deal Means Billions Missing From Vaccine Distribution

FILE - In this July 30, 2020 photo, Kai Hu, a research associate transfers medium to cells, in the laboratory at Imperial College in London. Imperial College is working on the development of a COVID-19 vaccine. In a ... FILE - In this July 30, 2020 photo, Kai Hu, a research associate transfers medium to cells, in the laboratory at Imperial College in London. Imperial College is working on the development of a COVID-19 vaccine. In a report to Congress and an accompanying “playbook” for states and localities, key federal health agencies and the Defense Department sketched out complex plans for a vaccination campaign to begin gradually early next year or later in 2020, eventually ramping up to reach any American who wants a shot. The Pentagon is involved with the distribution of vaccines, but civilian health workers will be the ones giving shots. (AP Photo/Kirsty Wigglesworth) MORE LESS
October 6, 2020 4:49 p.m.

President Trump’s decision to blow up talks over a relief package will deprive the COVID-19 vaccine distribution effort of billions of dollars in needed funds.

It dashes hopes for $6 billion that the Centers for Disease Control says it needs to distribute the vaccine, along with billions more requested to fund other parts of the herculean effort to get a vaccine to every American.

CDC Director Dr. Robert Redfield told a Senate appropriations subcommittee last month that his agency does not have the $6 billion it needs to distribute the vaccine.

“We need to get resources to states now,” Redfield told Sen. Roy Blunt (R-MO). “It’s going to take somewhere between $5.5 [billion] to $6 billion to distribute this vaccine.”

Get TPM in your inbox, twice weekly.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

“It’s as urgent as getting these manufacturing facilities up,” he added, referring to the factories that actually make the vaccine. Redfield said that the CDC had around $600 million to spend on distributing the vaccine without additional funding, but added that the agency does not have the resources “to get this plan operational, so to me it’s an urgency.”

Senate Republicans had supported the funding, including it in their vote last month on a relief bill that Democrats deemed as far too small to match the scale of catastrophe that currently faces the country.

Trump appeared to demolish the talks around COVID-19 relief with a series of mid-afternoon tweets in which he announced that he was walking away from the table.

GOP leadership had expressed support for funding vaccine distribution.

Senate Majority Leader Sen. Mitch McConnell (R-KY) used the funding in September 10 remarks as a bludgeon against Democrats voting against the the otherwise meager relief legislation.

“They’re going to vote against finding and distributing vaccines because they are afraid the breakthrough that our nation is praying for might possibly help President Trump,” McConnell said in the remarks.

It’s not clear that the $6 billion the CDC says it needs would even be close to enough to effectively and quickly distribute the vaccine.

At the September hearing, Sen. Blunt referred to “another $20 billion that [HHS] doesn’t have in any specifically appropriated line” in order to have 300 million doses of vaccine available for the entire U.S. population.

Separately, states and local public health officials have been pushing for more federal funding to distribute the vaccine, saying that requirements like cold storage for doses and follow-up monitoring for vaccine recipients mean states need at least $8.4 billion from Congress.

Latest Muckraker
Comments are now Members-Only

Non-members are still able to read comments, but will no longer be able to participate. To join the conversation, sign up now and get:

30% Off Annual Prime Membership

TPM strives to build as inclusive a community as financially possible. We offer FREE memberships to those experiencing financial hardship and FREE memberships for students.

View all options
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Audience Development Editor:
Editor at Large:
General Counsel:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: